Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Rapid and affordable genome-wide bisulfite DNA sequencing by XmaI-RRBS

ABSTRACT: We describe XmaI-RRBS method for rapid and affordable genome-wide DNA methylation analysis, with library preparation taking only four days and sequencing possible within four hours. Small sizes of the XmaI-RRBS libraries allow their multiplexing and sequencing on the benchtop high-throughput machines. Described here is the first RRBS protocol validated for the Ion Torrent Personal Genome Machine.

ORGANISM(S): Homo sapiens

PROVIDER: GSE74126 | GEO | 2015/11/01

SECONDARY ACCESSION(S): PRJNA299119

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Rapid and affordable genome-wide bisulfite DNA sequencing by XmaI-RRBS

Project description:We describe XmaI-RRBS method for rapid and affordable genome-wide DNA methylation analysis, with library preparation taking only four days and sequencing possible within four hours. Small sizes of the XmaI-RRBS libraries allow their multiplexing and sequencing on the benchtop high-throughput machines. Described here is the first RRBS protocol validated for the Ion Torrent Personal Genome Machine. DNA from MCF7 cell line and 6 normal breast samples (total 7 samples) were subjected to reduced representation bisulfite sequencing analysis (XmaI-RRBS) by using Ion Torrent platform.

2015-11-01 | E-GEOD-74126 | biostudies-arrayexpress

Homo sapiens

Project description:Rapid and affordable genome-wide bisulfite DNA sequencing by XmaI-RRBS

| PRJNA299119 | ENA

XmaI-RRBS on Luminal B breast carcinoma samples taken prior to chemotherapy

Project description:XmaI-RRBS on Luminal B breast carcinoma samples taken prior to chemotherapy

| PRJNA509934 | ENA

XmaI-RRBS on triple negative breast carcinoma samples taken prior to chemotherapy

Project description:XmaI-RRBS on triple negative breast carcinoma samples taken prior to chemotherapy

| PRJNA509628 | ENA

Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients

Project description:We investigated a panel of 21 genes by parallel sequencing on the Ion Torrent Personal Genome Machine platform. We sequenced 65 CRCs that were treated with cetuximab or panitumumab ( 37 samples were responsive and 28 were resistant).

2015-10-22 | E-MTAB-3883 | biostudies-arrayexpress

Targeted next generation sequencing of cfDNA from lung cancer patients enrolled in the GALAXY-1 trial (NCT01348126)

Project description:We evaluated whether targeted next-generation sequencing (NGS) using the Ion Torrent Personal Genome Sequencer of cfDNA could identify prognostic or predictive factors for overall survival (OS) or progression free survival (PFS) within a large cohort of patients with advanced lung adenocarcinoma enrolled in the GALAXY-1 trial.

2018-01-10 | E-MTAB-5749 | biostudies-arrayexpress

Transcriptional and epigenetic profiling of EP-derived iPSCs (RRBS)

Project description:We generated 20 iPSC lines from erythroid precursors (EP) and compared them to 3 lines derived from dermal fibroblasts (DF), H9 hESC, four precursor EP populations and one precursor DF population. This experiment describes the RRBS profiling of those samples performed in order to QC the lines. These Human samples are not consented for release of identifiable sequencing data, so processed methylation calls over CpG islands are provided.

2014-09-01 | E-MTAB-2711 | biostudies-arrayexpress

RRBS in MommeD43 NSCs

Project description:RRBS in MommeD43 NSCs

| PRJNA728107 | ENA

Targeted (amplicon) reduced representation bisulfite sequencing (RRBS) data for HGSOC PH039 PDXs at baseline and treated with cycles of 100 mg/kg niraparib for 21 days for four treatment rounds

Project description:Targeted (amplicon) reduced representation bisulfite sequencing (RRBS) data for HGSOC PH039 PDXs at baseline and treated with cycles of 100 mg/kg niraparib for 21 days for four treatment rounds.

2021-06-16 | GSE165051 | GEO

UBC RRBS

Project description:UBC RRBS

| OEX00023008 | NODE